When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM.

Bollam, Saumya R; Berens, Michael E; Dhruv, Harshil D

Bollam, Saumya R; Berens, Michael E; Dhruv, Harshil D.

Afiliación

Bollam SR; Division of Cancer and Cell Biology, Translational Genomics Research Institute, 445 N 5th Street, Phoenix, AZ, 85004, USA.
Berens ME; Division of Cancer and Cell Biology, Translational Genomics Research Institute, 445 N 5th Street, Phoenix, AZ, 85004, USA.
Dhruv HD; Division of Cancer and Cell Biology, Translational Genomics Research Institute, 445 N 5th Street, Phoenix, AZ, 85004, USA. hdhruv@tgen.org.

Curr Neurol Neurosci Rep ; 18(4): 15, 2018 03 10.

Article en En | MEDLINE | ID: mdl-29525892

Asunto(s)

Neoplasias Encefálicas/genética; Neoplasias Encefálicas/terapia; Glioma/genética; Glioma/terapia; Telomerasa/genética; Astrocitoma; Glioblastoma/genética; Glioma/patología; Humanos; Mutación; Regiones Promotoras Genéticas

Palabras clave

Cellular functions of TERT; GBM; Glioblastoma; TERT promoter mutation (TPM); Telomerase reverse transcriptase (TERT); Therapeutic targeting of TERT

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Telomerasa / Glioma Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Neurol Neurosci Rep Asunto de la revista: NEUROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google